MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2025 International Congress

    Pilot Study: Shear Wave Elastography as a Potential Biomarker in Task-Specific Dystonia

    A. Ly, A. Mushtaheed, A. Roberts, M. Druckenbrod, J. Stowers, M. Soliman, P. Lind, Y. Assefa, C. Stanley, A. Gravunder, J. Matsubara, C. Zampieri-Gallagher, D. Ehrlich, B. Karp, F. Gavelli, K. Alter (Bethesda, USA)

    Objective: The purpose of this study was to explore shear wave elastography (SWE)’s ability to identify task-specific dystonic muscles by determining if muscle stiffness increased…
  • 2025 International Congress

    Artificial Intelligence in the Early Detection of Parkinson’s Disease: Advances, Challenges, and Future Perspectives

    ME. Mellaci (SÃO PAULO, Brazil)

    Objective: This study reviews AI’s role in early PD detection, comparing AI-driven diagnostic methods with conventional clinical approaches in accuracy, reliability, and applicability. Background: Parkinson’s…
  • 2025 International Congress

    Deep Learning-Driven Discovery of Mitochondrial Genomic Instability in Parkinson’s Disease: A Single-Cell Multi-Omics Approach

    R. Fajar, A. Ureng (Sleman, Indonesia)

    Objective: This study integrates snRNA-seq and proteomic data to (i) map mtDNA heteroplasmic mutations at single-cell resolution, (ii) identify mitochondrial-driven transcriptional dysregulation, and (iii) classify…
  • 2025 International Congress

    Improved Outcomes for Patients with Autonomic Movement Disorders (AMD) Originally Evaluated for Psychogenic Non-Epileptiform Spells (PNES)

    A. Khoo, J. Brik, M. Paul, A. Hohler (Boston, USA)

    Objective: To evaluate whether treating underlying dysautonomia in patients with abnormal movements initially diagnosed with psychogenic non-epileptiform spells (PNES) leads to a reduction in motor…
  • 2025 International Congress

    Dietary and Environmental Risk factors of Parkinson’s Disease: An integrated study combining Network Pharmacology and Molecular Docking Analyses

    D. Ghosh, P. Basu, S. Mondal, S. Pal (Kolkata, India)

    Objective: This large-scale case-control study using network pharmacology and molecular docking, aimed to identify dietary and environmental risk factors of Parkinson’s disease (PD). Background: PD…
  • 2025 International Congress

    Validating Real-World Evidence for Identifying Adverse Events Related to a Deep Brain Stimulation Implant

    J. Joseph, Y. Pathak, C. Salazar, A. Benison (Plano, USA)

    Objective: This study aims to validate Real-world evidence (RWE) using claims-based algorithms to identify adverse events (AEs) among patients implanted with a Deep Brain Stimulation…
  • 2025 International Congress

    Optimizing Bereitschaftspotential Detection Using Signal Processing Techniques

    B. Hale, R. Kandasamy, C. Cordivari (London, United Kingdom)

    Objective: Apply signal processing methods for more robust Bereitschaftspotential detection Background: The Bereitschaftspotential (readiness potential, BP) is a small, slow rising negative scalp EEG potential…
  • 2025 International Congress

    The Phenomena of “Meryacheniye” and “Kliukushestvo” in Yakutia in the 20th Century

    M. Andreev, S. Sleptsov, O. Polovinko (Moscow, Russian Federation)

    Objective: To review the characteristics of psychogenic movement disorders in Yakutia. Background: At the beginning of the 20th century, the conditions known as “meryacheniye” and…
  • 2025 International Congress

    CAPOS Phenotypic Spectrum: CAPOS, CAPOS+ and CAPOS- within the p.Glu831Lys Variant of the ATP1A3 gene. Case Report and Literature Review.

    E. Olivas-Domínguez, R. Romero-Armenta, M. Ramírez-García, H. Martínez-Hernández (Mexico City, Mexico)

    Objective: To describe and compare the clinical phenotype and frequency of symptom presentation of p.Glu831Lys variant associated syndrome within the ATP1A3 gene, adding the first…
  • 2025 International Congress

    Physical, Mental, and Socioemotional Functional Improvement Following Valbenazine Treatment for TD: a Case Series

    R. Bera, J. Nedzesky, I. Gandayuwana, D. Winkelman, D. Vanderhoef, M. Bron, M M. Perez-Rodriguez (San Diego, USA)

    Objective: Describe clinical characteristics and changes in mental, socioemotional, and physical domains of individuals with tardive dyskinesia (TD) after valbenazine (VBZ) treatment. Background: Prior research…
  • « Previous Page
  • 1
  • …
  • 71
  • 72
  • 73
  • 74
  • 75
  • …
  • 1734
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley